ARROWHEAD PHARMACEUTICALS, INC. — Director's Dealing 2017

Jan 5, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
CIK: 0000879407
Period of Report: 2017-01-01

Reporting Person: Myszkowski Kenneth Allen (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-01-01	Common Stock	A	145000	$0.00	Acquired	260689	Direct

Footnotes

F1: Represents shares underlying a restricted stock unit, which shares will vest in one installment in January 2019.